Article Dans Une Revue Leukemia Research Année : 2014

Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia

Dates et versions

hal-05235318 , version 1 (02-09-2025)

Identifiants

Citer

Concetta Quintarelli, Biagio de Angelis, Santa Errichiello, Simona Caruso, Nicola Esposito, et al.. Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. Leukemia Research, 2014, 38 (2), pp.236-242. ⟨10.1016/j.leukres.2013.11.006⟩. ⟨hal-05235318⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

  • More